Alexander Tang
Senior Associate

Services & Specializations
Admissions
California;
US Patent & Trademark Office
Languages
Mandarin
Address
200 Spectrum Center Drive, Suite 1650, Irvine, CA 92618
Office Tel.
949.381.6177
Overview
Alex advises early-stage companies through their late stages and exits on a variety of matters, including venture capital financings, M&A, and capital markets. He represents clients in a variety of industries including technology and life sciences, and brings in-house experience, having advised on ongoing matters including an initial public offering, intellectual property portfolio, privacy compliance, advertisements, social media, and drafting and negotiating various contracts.
M&A Transactions
- Represented an influencer marketing campaign software platform in a $400,000,000 merger with a strategic buyer.
- Represented a cosmetic manufacturing company in a $123,000,000 sale of 100% of capital stock to a private equity firm.
- Represented a crypto-wallet company in a $110,000,000 acquisition by a strategic buyer.
- Represented four related security consulting companies with nationwide operations in its $100,000,000 sale of 100% of capital stock to a private equity firm.
- Represented a public semi-conductor company in various strategic acquisitions and investments, including a $60,000,000 purchase of a voice processing software company.
- Represented an information technology software company in its $22,000,000 sale of 100% of capital stock to a Singapore based private equity firm.
Venture Capital / Private Placement Transactions
- Represented a pharmaceutical company in a $125,000,000 Series B financing.
- Represented an e-commerce company in a $100,000,000 minority investment by a private equity firm.
- Represented a biotechnology company in a $64,000,000 Series B financing.
- Represented a health software company in a $45,000,000 minority investment by a private equity firm and secondary sale of stock to the minority investor.
- Represented a biotechnology company in a $32,000,000 Series D down round financing.
- Represented a publicly traded biotechnology company in several private investments in private equity (PIPE) offerings of common stock, common warrants, and equity-linked securities.
Corporate Restructure and Other Transactions
- Represented multiple publicly traded life science and technology companies with various filings with the Securities and Exchange Commission (SEC) and NASDAQ.
- Represented multiple life science and e-commerce companies in their initial public offering, follow-on offerings, ATMs and S-3 shelf offerings.
- Best Lawyers® Ones to Watch, Corporate Law, 2026
- Super Lawyers® Rising Stars, Business & Corporate, 2025
- JD, Santa Clara University School of Law, Santa Clara, CA, 2018
- BS (Chemistry), University of California Riverside, 2014
- Asian Business League of Southern California, President and Board Member, 2024-present